CCCRC
 
MANSOUR SAIF AL-MOUNDHRI
Chairman, Operational Committee, SQCCCRC

1. Positions
Chairman, Operational Committee
Sultan Qaboos Comprehensive Cancer Care and Research CentreNov 2018 – Present
Professor of Medicine
May 2011 – Present
Associate Professor of Medicine
College of Medicine & Health Sciences, SQUJun 2006 to 2011
Consultant Medical Oncologist and Physician
Sultan Qaboos University Hospital (SQUH)Jun 1999 to Present
Assistant Professor in Medicine
College of Medicine and Health Science, SQUJun 1999 – Jun 2006
Honorary Senior Registrar and Clinical Research Fellow
Royal Marsden Hospital and Cancer Research Institute, Sutton, Surrey, UKFeb 1997 – Mar 1999
Advanced Trainee in Medical Oncology
Departments of Medical Oncology and Hematological Oncology St Vincent Hospital, Sydney, Australia, Department of Radiation Oncology, St George Hospital, Sydney, AustraliaOct 1994 – Feb 1997
Basic Trainee in Medicine
Departments of Medical Oncology, Palliative care, Geriatrics Medicine, and Respiratory Medicine, St Vincent Hospital, Sydney, AustraliaOct 1993 – Jul 1994
Senior House Officer in Medicine,
Department of Medicine, SQUHOct 1991 – Sep 1993
Junior House Officer in Medicine &
Department of Medicine, Glasgow Royal Infirmary & Department of Surgery, Stobhill Hospital, Glasgow, UKJul 1990 – Jul 1991
2. Education/training
Doctorate of Medicine
University of Glasgow, UK1999

Medical Oncology

FRACP
Royal Australasian College of Physicians, Sydney, Australia1997

Medical Oncology

MRCP (UK)
Royal Colleges of Physicians, UK1995

Medicine

MB. ChB.
Royal Colleges of Physicians, UK1990

Bachelor of Medicine & Surgery

Bachelor of Science
College of Medicine, University of St Andrews, UK1986

Medical Science

3. Selected peer-reviewed Publications

1. Hassan MM, Al-Marzooq D, Al-Habsi H, Al-Hashar A, Al-Khabori M, Al-Moundhri M, Al-Zakwani I. Patients’ knowledge and awareness of safe handling of oral anticancer agents at Sultan Qaboos University Hospital in Oman. J Oncol Pharm Pract. 2021 Nov 18:10781552211056238. doi: 10.1177/10781552211056238. Epub ahead of print. PMID: 34791932. 

2. Al-Maqrashi Z, Burney IA, Taqi KM, Al-Sawafi Y, Qureshi A, Lakhtakia R, Mehdi I, Al-Bahrani B, Kumar S, Al-Moundhri M. Clinicopathological Features and Outcomes of Gastrointestinal Stromal Tumours in Oman: A multi-centre study. Sultan Qaboos Univ Med J. 2021 May;21(2):e237-e243. doi: 10.18295/squmj.2021.21.02.012. Epub 2021 Jun 21. PMID: 34221471; PMCID: PMC8219329. 

3. D’Souza PC, Kumar S, Kakaria A, Al-Sukaiti R, Al-Baimani K, Hamid RS, Mittal AK, Al-Balushi M, Burney IA, Al-Moundhri MS. Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman. Sultan Qaboos Univ Med J. 2021 Feb;21(1):e103-e109. doi: 10.18295/squmj.2021.21.01.014. Epub 2021 Mar 15. PMID: 33777430; PMCID: PMC7968907. 

4. Malgundkar SH, Burney I, Al Moundhri M, Al Kalbani M, Lakhtakia R, Okamoto A, Tamimi Y. E2F5 Promotes the Malignancy of Ovarian Cancer Via the Regulation of Hippo and Wnt Pathways. Genet Test Mol Biomarkers. 2021 Mar;25(3):179-186. doi: 10.1089/gtmb.2020.0166. PMID: 33734894. 

5. Al Suqri M, Al-Awaisi H, Al-Moundhri M, Al-Azri M. Symptom Perceptions and Help-Seeking Behaviours of Omani Patients Diagnosed with Late-Stage Colorectal Cancer: A Qualitative Study. Asian Pac J Cancer Prev. 2021 Feb 1;22(2):427-435. doi: 10.31557/APJCP.2021.22.2.427. PMID: 33639657; PMCID: PMC8190347. 

6. Yousuf H, Kumar S, Al-Moundhri M. Rarest of the Rare Metastatic Tubulocystic Carcinoma of Kidney. Cureus. 2020 Dec 17;12(12):e12117. doi: 10.7759/cureus.12117. PMID: 33354487; PMCID: PMC7746312.  

7. Malgundkar SH, Burney I, Al Moundhri M, et al. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer. BMC Cancer. 2020;20(1):374. Published 2020 May 4. doi:10.1186/s12885-020-06900-7

8. Alsumait AF, Al-Farsi YM, Waly MI, et al. Hospital Prevalence of Colorectal Cancer among Colonoscopy Recipients Attending a Tertiary Hospital in Oman: A Cross-Sectional Study. ScientificWorldJournal. 2020;2020:5863126. doi:10.1155/2020/5863126

9. Kumar S, Furrukh M, Al-Baimani K, Al-Ajmi A, Burney IA, Al-Moundhri MS. Outcomes of Women with Non-Metastatic Triple-Negative Breast Cancer in Oman: A single-centre experience. Sultan Qaboos Univ Med J. 2019;19(3):e209‐e216. doi:10.18295/squmj.2019.19.03.006

10. Zahid KF, Kumar S, Al-Bimani K, Ahmed T, Al-Ajmi A, Burney IA, Al-Moundhri M.. Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital. Oman Med J. 2019;34(5):412‐419. doi:10.5001/omj.2019.76

11. Mafiana RN, Al-Kindi MS, Mafiana N, Al Lawati AS, Al Moundhri M. Impact of Metabolic Syndrome Diagnosis and Its Treatment on Survival of Colorectal Cancer Patients. J Cancer Epidemiol. 2019;2019:6527457. doi:10.1155/2019/6527457

12. Al-Zeheimi N, Naik A, Bakheit CS, Al Riyami M, Al Ajarrah A, Al Badi S, Al Baimani K, Malik K, Al Habsi Z, Al Moundhri MS, Adham SA. Neoadjuvant Chemotherapy Alters Neuropilin-1, PlGF, and SNAI1 Expression Levels and Predicts Breast Cancer Patients Response. Front Oncol. 2019;9:323. doi:10.3389/fonc.2019.00323

13. Qureshi A, Al-Moundhri M, Al-Shaibi M, Al-Haddabi I, Mittal A. Primary Gastric Yolk Sac Tumour. Sultan Qaboos Univ Med J. 2018;18(3):e383‐e385. doi:10.18295/squmj.2018.18.03.020

14. Mafiana RN, Al Lawati AS, Waly MI, Al Farsi Y, Al Kindi M, Al Moundhri M. Association between Dietary and Lifestyle Indices and Colorectal Cancer in Oman: A Case-Control Study. Asian Pac J Cancer Prev. 2018;19(11):3117‐3122. Published 2018 Nov 29. doi:10.31557/APJCP.2018.19.11.3117

15. Al-Bahri A, Al-Moundhri M, Al-Mandhari Z, Al-Azri M. Role of the family in Treatment Decision-Making process for Omani women diagnosed with breast cancer. Patient Educ Couns. 2019;102(2):352‐359. doi:10.1016/j.pec.2018.08.026

16. Al-Bahri A, Al-Moundhri M, Al-Azri M. The Role of Patients’ Families in Cancer Treatment Decision-Making: Perspectives among Eastern and Western families. Sultan Qaboos Univ Med J. 2017;17(4):e383‐e385. doi:10.18295/squmj.2017.17.04.001

17. Furrukh M, Kumar S, Zahid KF, Al-Shamly HS, Al-Jabri ZA, Burney IA, Al-Moundhri MS. Trends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital. Sultan Qaboos Univ Med J. 2017;17(3):e301‐e308. doi:10.18295/squmj.2017.17.03.007

18. Gupta I, Burney I, Al-Moundhri MS, Tamimi Y. Molecular genetics complexity impeding research progress in breast and ovarian cancers. Mol Clin Oncol. 2017;7(1):3‐14. doi:10.3892/mco.2017.1275

19. Naik A, Al-Zeheimi N, Bakheit CS, Al Riyami M, Al Jarrah A, Al Moundhri MS, Al Habsi Z, Basheer M, Adham SA. Neuropilin-1 Associated Molecules in the Blood Distinguish Poor Prognosis Breast Cancer: A Cross-Sectional Study. Sci Rep. 2017;7(1):3301. doi:10.1038/s41598-017-03280-0

20. Alkhasawneh E, Siddiqui ST, Leocadio M, Seshan V, Al-Farsi Y, Al-Moundhri MS. I Do Not Even Say “It” – a Mixed Methods Study on Breast Cancer Awareness of Omani Women. Asian Pac J Cancer Prev. 2016;17(4):2247-54.  

21. Al-Khanbashi M, Caramuta S, Alajmi AM, Al-Haddabi I, Al-Riyami M, Lui W-O, Al-Moundhri M. (2016) Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment. PLoS ONE 11(4): e0152032. doi:10.1371/journal.pone.0152032

22. M Al-Khanbashi, M Al-Moundhri. Micro-ribonucleic acid and carcinogenesis: breast cancer as an example. http://dx.doi.org/10.4081/oncol.2015.279

23. Kumar S, Burney IA, Zahid KF, D Souza PC, Belushi MA, Mufti TD, Meki WA, Furrukh M, Al Moundhri MS. Colorectal Cancer Patient Characteristics, Treatment and Survival in Oman – a Single Center Study. Asian Pac J Cancer Prev. 2015; 16(12):4853-8.  

24. Yahya Tamimi1, Ishita Gupta, Mansour Al-Moundhri, Ikram Bureny. Micrometastatic Circulating Tumor cells; A Challenge for an Early Detection and Better Survival Rates. J Carcinog Mutagen 6: 229. doi:10.4172/2157-2518.1000229

25. Adham SA, Al Rawahi H, Habib S, Al Moundhri MS, Viloria-Petit A, Coomber BL.Modeling of Hypo/Hyperglycemia and Their Impact on Breast Cancer Progression Related Molecules. PLoS One. 2014 Nov 17;9(11):e113103. doi: 10.1371/journal.pone.0113103. eCollection 2014.  

26. Galaal K, Al Moundhri M, Bryant A, Lopes AD, Lawrie TA.Adjuvant chemotherapy for advanced endometrial cancer. Cochrane Database Syst Rev. 2014 May 15;5:CD010681. doi: 10.1002/14651858.CD010681.pub2

27. Burney IA, Furrukh M, Al-Moundhri MS.What are our Options in the Fight against Breast Cancer? Sultan Qaboos Univ Med J. 2014 May;14(2):e149-51. Epub 2014 Apr 7 

28. Kumar S, Burney IA, Al-Moundhri MS.Near complete resolution of refractory, relapsed, metastatic Wilms’ tumour in an adolescent with bevacizumab. J Coll Physicians Surg Pak. 2014 Mar;24 Suppl 1:S71-2. doi: 03.2014/JCPSP.S71S72.  

29. Tamimi Y, Al-Harthy S, Al-Haddabi I, Al-Kindi M, Babiker H, Al-Moundhri M, Burney I.The p53 Mutation/Deletion Profile in a Small Cohort of the Omani Population with Diffuse Large B-Cell Lymphoma. Sultan Qaboos Univ Med J. 2014 Feb;14(1):e50-8. Epub 2014 Jan 27.  

30. Al-Azri MH, Al-Awisi H, Al-Rasbi S, Al-Moundhri M. Coping with a diagnosis of breast cancer amongst Omani women.J Health Psychol. 2013 Mar 21.  

31. Machado L, Al-Hamdani A, Sankhla DK, Al-Moundhri. MS. Extraosseous Ewing sarcoma of the vagina: a rare entity.Ann Saudi Med. 2013 Mar-Apr;33(2):182-6.  

32. Furrukh M, Burney IA, Kumar S, Zahid KF, Al-Moundhri M. Improving Outcomes in Advanced Lung Cancer: Maintenance therapy in non-small-cell lung carcinoma. Sultan Qaboos Univ Med J. 2013 Feb;13(1):3-18. Epub 2013 Feb

33. Ali A, Al-Belushi BS, Waly MI, Al-Moundhri M, Burney IA. Dietary and Lifestyle Factors and Risk of Non-Hodgkin’s Lymphoma in Oman. Asian Pac J Cancer Prev. 2013;14(2):841-8.  

34. Furrukh M, Al-Moundhri M, Zahid KF, Kumar S, Burney I. Customised, Individualised Treatment of Metastatic Non-Small-Cell Lung Carcinoma (NSCLC).Sultan Qaboos Univ Med J. 2013 May;13(2):202-17.  

35. Al-Moundhri MS, Al-Ansari A, Al-Mawali K, Al-Bahrani B. BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients. Gulf J Oncolog. 2013 Jul;1(14):45-51.  

36. Al-Moundhri M. The need for holistic cancer care framework: breast cancer care as an example .Oman Med J. 2013 Sep;28(5):300-1.  

37. Aljarrah A, Al-Hashmi M, Malik KA, Sukhpal S, Hussein S, Al-Riyami M, Al-Moundhri M. Mucinous breast cancer with solitary metastasis to humeral head: a case report. Oman Med J. 2013 Sep;28(5):350-3.  

38. Burney IA, Al-Moundhri MS. From Transplant to Tablets: A paradigm shift in Oncology.Sultan Qaboos Univ Med J. 2012 Nov;12(4):402-5. Epub 2012 Nov 20.  

39. Furrukh M, Burney IA, Kumar S, Zahid KF, Al-Moundhri M. Improving Outcomes in Advanced Lung Cancer: Maintenance therapy in non-small-cell lung carcinoma. Sultan Qaboos Univ Med J. 2013 Feb;13(1):3-18.  

40. Al-Azri MH, Al-Awisi H, Al-Rasbi S, Al-Moundhri M. Coping with a diagnosis of breast cancer amongst Omani women. J Health Psychol. 2013 Mar 21

41. Al-Moundhri MS, Al-Hadabi I, Al-Mawaly K, Kumar S, Al-Lawati FA, Bhatnager G, Kuruvila S, Al-Hamdani A, El-Sayed SM, Al-Bahrani B. Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer. Med Oncol. 2011 Nov 3

42. Rusiecki JA, Al-Nabhani M, Tarantini L, Chen L, Baccarelli A, and Al-Moundhri MS. Global DNA methylation and tumor suppressor gene promoter methylation in whole blood and gastric cancer risk in an Omani Arab population. Epigenomics, August 2011; 3(4); 417-429.  

43. Ali BH, Abdelrahman AM, Al-Salam S, Sudhadevi M, Almahruqi AS, Al-Husseni IS, Beegam S, Dhanasekaran S, Nemmar A, Al-Moundhri M. The Effect of Sildenafil on Cisplatin Nephrotoxicity in Rats. Basic Clinical Pharmacology Toxicology. 2011 May 16. doi: 10.1111/j.1742-7843.2011.00724.x.  

44. Waly MI, Al- Moundhri MS, Ali BH..Effect of Curcumin on Cisplatin- and Oxaliplatin-Induced Oxidative Stress in Human Embryonic Kidney (HEK) 293 Cells. Renal Failure. 2011;33(5):518-23.  

45. Al-Moundhri MS, Al-Nabhani M, Tarantini L, Baccarelli A, Rusiecki JA. 

The prognostic significance of whole blood global and specific DNA methylation levels in gastric adenocarcinoma. PLoS One. 2010 Dec 23;5(12):e15585.  

46. Kumar S,. Burney IA, Al-Ajmi A, and Al-Moundhri MS . Changing trends of breast cancer survival in a developing country-Oman. Journal of Oncology.2011;2011:316243.  

47. Al-Moundhri MS, Al-Lawatia J. Cancer Report of Asian-Pasific Region 2010. Sultanate of Oman chapter. Pages 90-99

48. Al-Moundhri MS, Al-Khanbashi M, Al-Kindi M, Al-Nabhani M, Burney IA, Al-Farsi A, Al-Bahrani B. Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World Journal of Gastroenterology. 2010 Jul 21;16(27):3432-6

49. Al-Azri M, Al-Awisi H, Al-Moundhri M. Coping with a diagnosis of breast cancer-literature review and implications for developing countries. Breast J. 2009 Nov-Dec;15(6):615-22 

50. Al-Moundhri MS, Al-Nabhani M, Burney IA, Al-Farsi AA, Al-Bahrani B. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms–a case-control study in an Omani population. Molecular Carcinogenesis. 2009 Dec;48(12):1170-6.  

51. Ahmed S, Burney I, Sawhney S, Al Moundhri MS. Gastric Adenocarcinoma in Association with Tuberous Sclerosis. Sultan Qaboos University Medical Journal ; April 2009; 9(1 ) :81-84.  

52. Al-Moundhri MS, Al-Kindi M, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Habsi H, Ganguly SS, Tanira M. Combined polymorphism analysis of glutathione S-transferase M1/G1 and interleukin 1 B (IL-1B)/interleukin 1-receptor antagonist (IL-1RN) and gastric cancer risk in an Omani population. Journal of Clinical Gastroenterology. 2009 Feb;43(2):152-6.’

53. Ali BH, Al-Moundhri M, Tageldin M, Al Husseini IS, Mansour MA, Nemmar A, Tanira MO. Ontogenic aspects of cisplatin-induced nephrotoxicity in rats. Food and Chemical Toxicology. 2008 Nov;46(11):3355-9.  

54. Brim H, Mokarram P, Naghibalhossaini F, Saberi-Firoozi M, Al-Mandhari M, Al-Mawaly K, Al-Mjeni R, Al-Sayegh A, Raeburn S, Lee E, Giardiello F, Smoot DT, Vilkin A, Boland CR, Goel A, Hafezi M, Nouraie M, Ashktorab H. Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study. Molecular Cancer. 2008 Aug 21;7:68.  

55. Burney I A and Al-Moundhri M S. Major Advances in the Treatment of Cancer: What does a Non-Oncologist need to know? Sultan Qaboos University Medical Journal. July 2008 ;. 8( 2) :137-148

56. Al-Moundhri MS, Al-Shukaili A, Al-Nabhani M, Al-Bahrani B, Burney IA, Rizivi A, Ganguly SS.Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma. World Journal of Gastroenterology. 2008 Jun 28;14(24):3879-83.  

57. Ali BH, Al- Moundhri MS, Tag Eldin M, Nemmard, A, Tanira MO. Amelioration of cisplatin-induced nephrotoxicity in rats by tetramethylpyrazine, a pure compound from the Chinese herb Ligusticum wallich. Experimental Biology Medicine (Maywood). 2008 Jul;233(7):891-6.  

58. Burney I A, Al- Moundhri MS, Rizvi AJ, Ganguly SS, Al Abri R, Rafi A. Outcome as a Measure of Quality of Care in Oncology : Experience at Sultan Qaboos University Hospital, Oman . Sultan Qaboos University Medical Journal 2008 March; 8( 1) :27-36

59. Alansari AS, Al-Moundhri M, Al-Nabhani MM, Al-Zidjali SA. BRCA1 2080insA mutation in familial breast cancer. Breast Cancer Research and Treat. 2009 Feb;113(3):605-6.  

60. Ashktorab H, Brim H, Al-Riyami M, Date A, Al-Mawaly K, Kashoub M, Al-Mjeni R, Smoot DT, Al-Moundhri M, Al-Hashemi S, Ganguly SS, Raeburn S. Sporadic colon cancer: Mismatch repair immunohistochemistry and microsatellite instability in Omani subjects. Digestive Diseases and Sciences. 2008 Oct;53(10):2723-31.  

61. Burney I A, Nirmala V, Al-Moundhri MS, Woodhouse NJ. Nodular Lymphocyte Predominant Hodgkin’s Lymphoma Presenting as Severe Hypercalcaemia: A Case Report . Sultan Qaboos University Medical Journal, 2007 December ; 7 (3) :247-251

62. Ali BH, Al Moundhri MS, Tag Eldin M, Nemmard, A, Tanira MO. The ameliorative effect of cysteine Prodrug L-2-oxothiazolidine-4-carboxylic acid on cisplatin-induced nephrotoxicity in rats. Fundamental Clinical Pharmacology. 2007 Oct;21(5):547-53.   

63. Al-Moundhri MS, Al-Kindi M, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, Tanira M. NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations. World Journal of Gastroenterology. 13(19):2697-702, 2007.  

64. Al-Shukaili A, Al-Jabri AA, Al-Moundhri MS. Prognostic value of auto-antibodies in the serum of Omani patients with gastric cancer. Saudi Medical Journal. 2006 Dec;27(12):1873-7.  

65. Al-Moundhri MS, Al Nabhani M, Al Bahrani B, Burney IA, Al Madhani A, Ganguly SS, Yahyayee SA, Grant CG. Interleukin-1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer. 9(4):284-90, 2006.  

66. Al-Moundhri MS, Al-Thahli K, Al-Kindy S, Salam J, Rao L. Metastatic gastrointestinal stromal tumor and hypercalcemia in a patient with ulcerative colitis. Saudi Medical Journal. 2006 Oct;27(10):1585-7.     

67. Al-Moundhri MS, Al-Bahrani B, Burney IA, Nirmala V, Al-Madhani A, Al-Nabhani M, Thomas V, Ganguly SS, Grant CS. The clinicopathological features, treatment and survival of gastric adenocarcinoma in Omani Arab patients. Asia-Pacific Journal of Clinical Oncology, Vol. 2, No. 3. (September 2006), pp. 137-143

68. Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research. Food and Chemical Toxicology. 2006 Aug;44(8):1173-83.  

69. Al-Moundhri MS, Al-Bahrani B, Burney IA, Nirmala V, Al-Madhani A, Al-Mawaly K, Al-Nabhani M, Thomas V, Ganguly SS, Grant CS. The prognostic determinants of gastric cancer treatment outcome in Omani Arab patients. Oncology. 2006;70(2):90-6.  

70. Al-Moundhri MS, Nirmala V, Al-Hadabi I, et al.: The prognostic significance of p53, p27(kip1), p21(waf1), HER-2/neu, and Ki67 proteins expression in gastric cancer: A clinicopathological and immunohistochemical study of 121 Arab patients. Journal of Surgical Oncology 2005;91:243-252.  

71. Al-Moundhri M, Al-Bahrani B, Pervez I, et al.: The outcome of treatment of breast cancer in a developing country–Oman. Breast 2004;13:139-145.  

72. Al-Moundhri M, Nirmala V, Al-Mawaly K, et al.: Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer. Pathology Oncology Reserach 2003;9:226-231.  

73. Rogers PM, Beale PJ, Al-Moundhri M, Boxall F, Patterson L, Valenti M, Raynaud F, Hobbs S, Johnston S, Kelland LR. Overexpression of BclXL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo. International Journal of Cancer. 2002 Feb 20; 97(6):858-63.  

74. Al-Moundhri M, Mathew M, Krolikowski A. Synchronous bilateral endometrioid ovarian cancer and uterine adenocarcinoma in young women. SQU Journal for Scientific research: Medical Sciences.2001(1):51-53

75. Deleu D, Lagopoulos M, al Moundhry M, Katchy K. Isolated bilateral abducens nerve palsy in primary sphenoidal sinus non-Hodgkin lymphoma. Acta neurologica belgica. 2000 Jun;100(2):103-6

76. Johnston SRD, Al-Moundhri M, Valenti M, Kelland R, Gore ME. Paclitaxel resistance in human Ovarian Cancer: role of apoptosis-related proteins in vivo. In Ovarian Cancer. CH6, 1999- Book Chapter; pages: pages 399-306.  

77. Smith IE, al-Moundhri M. Primary chemotherapy in breast cancer. Biomedicine & Pharmacotherapy. 1998; 52(3):116-21.  

78. Al-Moundhri M, O’Brien M, Souberbielle BE. Immunotherapy in lung cancer. British Journal of Cancer. 1998 Aug; 78(3):282-8.  

79. Al-Moundhri M, Graham PH. Splenic irradiation for hairy cell leukaemia. Australasian Radiology. 1997 Nov; 41(4):361-2.  

80. Al-Moundhri M, Ezzie J, Ward R. Rectal administration of ondansetron in uncontrolled emesis induced by chemotherapy. Australian New Zealand Journal of Medicine. 1995 Oct; 25(5):538.  

CCCRC
X